about
Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartmentsIL15 and T-cell Stemness in T-cell-Based Cancer ImmunotherapyDopamine inhibits the effector functions of activated NK cells via the upregulation of the D5 receptorLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Comparison of Fibronectin and Collagen in Supporting the Isolation and Expansion of Endothelial Progenitor Cells from Human Adult Peripheral Blood.Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individualsExpanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions.Dual REST-dependence of L1CAM: from gene expression to alternative splicing governed by Nova2 in neural cells.Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.A prospective observational study of associated anomalies in Hirschsprung's disease.Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients.Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys.HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blastsLysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.NK cells in HIV infection: paradigm for protection or targets for ambush.Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid TissuesHuman liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy.Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages.Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes.The role of natural killer cells in autoimmune liver disease: a comprehensive review.NK Cell Subset Redistribution during the Course of Viral Infections.Inflammation and preterm birth.Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways.Tissue-resident and memory properties of human T-cell and NK-cell subsets.Expression variability and function of the RET gene in adult peripheral blood mononuclear cells.Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication.Allele-specific expression at the RET locus in blood and gut tissue of individuals carrying risk alleles for Hirschsprung disease.Curtailed T-cell activation curbs effector differentiation and generates CD8+ T cells with a naturally-occurring memory stem cell phenotype.Increased Frequency and Vasculogenic Potential of Endothelial Colony-Forming Cells in Patients with Kaposi's Sarcoma.Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.Novel multifunctional antibody approved for the treatment of breast cancer.
P50
Q21144775-8224932A-E1EF-4BAB-A7B5-52F14E6F8153Q28088543-D9E268C0-CA6A-46DC-998F-0311275958C0Q28246046-EFF1B99E-4926-4192-B34A-9574B1929B7CQ30845033-D03AB1B3-80C5-4DCC-BB57-A55FEE8B8C3CQ31122581-30E775D6-3BDD-4D6C-BFC5-879FBAA95CFDQ33604765-FEA404A0-508D-41A3-A6E4-21C361465E03Q33864775-7FE78D96-3E3F-4493-A730-BCA0888A3343Q33938500-3931ED05-69A6-4080-8D9D-4BAC7B422C65Q34241180-212788E5-129A-4F40-90B8-20E99E38370BQ34389699-BA52DB63-4655-4692-9A26-FF8AE359C391Q34430165-865B6DFC-9927-48C9-B775-15D71DD96E7DQ34461709-0AEC1BF6-F7E1-4C86-9B73-0CAAD4C99911Q34634596-A7900D1B-003F-408D-908C-3A3479AB00A2Q35584266-34CCD1D5-20D4-4A32-8F51-A3F7B21E338BQ35848120-A5BD7C7C-909C-474F-AD5A-EBC62A17B489Q35925041-BB257782-23B9-4743-96A1-C89FB9FB8FD3Q36064034-E43754EC-B5CC-4C99-A329-815A6DB44A9EQ36227999-F7446E1D-DE79-446C-9097-9CBD475FABD3Q36292864-33F07D4E-C29D-4968-8955-017FF991CD19Q36410178-FFEF79DC-5E06-4A39-AD54-DBF1A8E05AC2Q36479523-7F8D7417-1C77-495F-91CB-EB89BDD9337FQ36701917-7EBA89F9-921B-44B0-81D1-1A1660E7CB42Q37197620-FEBA3C51-F673-4AB0-9CFB-209641ABF3E4Q37233039-5712F656-3C10-419B-B1EE-5AC0D3C7AD7CQ37427096-AE1F1315-7FEB-4C2F-8323-8935C6DB8462Q37716750-37443871-58D8-4092-9FE9-323A39B13FFCQ37774818-58A4438B-4327-4E8D-ACA9-612A06AEC812Q38123581-B78DE278-342A-4F09-9889-E5E4D9643922Q38245228-40D91FBE-0C65-41B4-817A-77BE0EBB1122Q38625684-3C2DADD9-6EA3-42FC-80EE-ACAF0F1AD44DQ38843483-A9A93B78-D293-4F1A-8E66-4BD37D85990FQ38901419-A23A0F28-F555-4A89-87BD-3F4231DEB84AQ39000564-A0A33773-7C0A-41F3-ACD8-55E0062D0E52Q39085363-123607B4-B924-4436-B2C0-9BA3B73FBBCFQ39188619-49DAB1DC-D29E-4964-A35D-0B6E0E226D51Q40149591-D1E1E3BB-6422-466A-8C36-3229CC2FDB12Q40296099-0EC2F3E9-9A2A-45B2-84FA-A655B5A4FE63Q40464037-3EB75BF2-614C-44A6-99D0-CB6441A3F574Q40528582-846DD287-0D9C-4508-876C-FE73E2BEC69AQ40930170-0572CB63-D93D-4CE7-B2B4-A0AC2F49D16A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Domenico Mavilio
@ast
Domenico Mavilio
@en
Domenico Mavilio
@es
Domenico Mavilio
@nl
Domenico Mavilio
@sl
type
label
Domenico Mavilio
@ast
Domenico Mavilio
@en
Domenico Mavilio
@es
Domenico Mavilio
@nl
Domenico Mavilio
@sl
prefLabel
Domenico Mavilio
@ast
Domenico Mavilio
@en
Domenico Mavilio
@es
Domenico Mavilio
@nl
Domenico Mavilio
@sl
P1053
E-5194-2017
P106
P1153
6603439694
P21
P2798
P31
P3829
P496
0000-0001-6147-0952